Oxford BioMedica To Acquire Oxxon

Oxford BioMedica (LSE: OXB) has agreed to acquire Oxxon Therapeutics Ltd., a UK-based therapeutic vaccine company, for Gbp16 million. Oxxon has raised over $30 million in VC funding since 200a, from firms like NeoMed Management, ISIS Capital, MVM Life Science Partners, NIF and Quester Capital Management. www.oxti.com